Talk:Mesalazine
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Mesalazine.
|
Methaeoglobinaemia
edit"Methaeoglobinaemia" is listed as a side effect. Should this be "Methaemoglobinaemia" (with an "m"), which redirects to Methemoglobinemia? Songdog 15:13, 8 March 2006 (UTC)
Mesalamine
editContent moved from mesalamine to mesalazine to reflect the International Nonproprietary Name rather than the United States Approved Name PeteThePill 22:55, 18 Jun 2005 (UTC)
Lialda
editThe section describing Lialda sounds a little bit like a sales pitch for the drug. The other formulations are not really mentioned much, and it seems to be emphasizing benefits of Lialda that don't seem proven yet. I'm just a layperson when it comes to this stuff, so please take my comment with a grain of salt. —Preceding unsigned comment added by 198.135.207.129 (talk) 16:19, 17 January 2008 (UTC)
Mode of action?
editHow does the drug work? If this is not known, it should be said that such information is unavailable. —Preceding unsigned comment added by 99.238.142.12 (talk) 22:21, 25 August 2008 (UTC)
Asacol is banned now by the FDA and in several countries due to the presence of dibutyl phthalate, I think it is worth mentioning. The ban also suspeciously comes just as the patent was expiring and the new patent for drug Delzicol came. — Preceding unsigned comment added by 117.192.242.244 (talk) 06:01, 30 January 2014 (UTC)
Advert?
editThis page supposedly on a generic drug reads like an advert for Apriso — Preceding unsigned comment added by 194.176.105.132 (talk) 17:12, 23 May 2012 (UTC)
- I removed some of the Apriso stuff and reorganized some of the content. -- Ed (Edgar181) 20:32, 24 May 2012 (UTC)
"PENTASA" listed at Redirects for discussion
editAn editor has asked for a discussion to address the redirect PENTASA. Please participate in the redirect discussion if you wish to do so. Whywhenwhohow (talk) 02:22, 10 December 2019 (UTC)